Proprietary Prime Editing Technology Platform: The company possesses exclusive rights to Prime Editing, a novel "search and replace" gene editing tool capable of directly rewriting DNA sequences with high precision.

Broad Therapeutic Applicability: Prime Editing's versatility allows it to correct a wide range of genetic mutations, including point mutations, insertions, and deletions, thereby addressing a vast spectrum of genetic diseases that other technologies cannot.

Enhanced Precision and Safety Profile: The mechanism of Prime Editing avoids generating double-strand breaks in DNA, potentially leading to fewer off-target edits and a more favorable safety profile compared to CRISPR-Cas9-based methods.